It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
DNA methylation is a repressive epigenetic modification that is essential for development, exemplified by the embryonic and perinatal lethality observed in mice lacking de novo DNA methyltransferases (DNMTs). Here we characterise the role for DNMT3A, 3B and 3L in gene regulation and development of the mouse placenta. We find that each DNMT establishes unique aspects of the placental methylome through targeting to distinct chromatin features. Loss of Dnmt3b results in de-repression of germline genes in trophoblast lineages and impaired formation of the maternal-foetal interface in the placental labyrinth. Using Sox2-Cre to delete Dnmt3b in the embryo, leaving expression intact in placental cells, the placental phenotype was rescued and, consequently, the embryonic lethality, as Dnmt3b null embryos could now survive to birth. We conclude that de novo DNA methylation by DNMT3B during embryogenesis is principally required to regulate placental development and function, which in turn is critical for embryo survival.
DNA methylation is a repressive modification that is essential for development. Here the authors reveal a critical role for DNA methylation in placental development during pregnancy. Failure to properly establish placental DNA methylation patterns compromises not only placental function, but embryo survival.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Krueger, Christel 2
; Mellado-Lopez, Maravillas 3 ; Hemberger, Myriam 4
; Dean, Wendy 5
; Perez-Garcia, Vicente 3 ; Hanna, Courtney W. 6
1 Babraham Institute, Bioinformatics Programme, Cambridge, UK (GRID:grid.418195.0) (ISNI:0000 0001 0694 2777)
2 Babraham Institute, Bioinformatics Programme, Cambridge, UK (GRID:grid.418195.0) (ISNI:0000 0001 0694 2777); Babraham Institute, Epigenetics Programme, Cambridge, UK (GRID:grid.418195.0) (ISNI:0000 0001 0694 2777); Altos Labs Cambridge Institute, Bioinformatics Innovation Hub, Cambridge, UK (GRID:grid.418195.0)
3 Centro de Investigación Príncipe Felipe, Valencia, Spain (GRID:grid.418274.c) (ISNI:0000 0004 0399 600X)
4 University of Calgary, Department of Biochemistry and Molecular Biology, Cumming School of Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Department of Medical Genetics, Cumming School of Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Alberta Children’s Hospital Research Institute, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697)
5 University of Calgary, Alberta Children’s Hospital Research Institute, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Department of Cell Biology and Anatomy, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697)
6 Babraham Institute, Epigenetics Programme, Cambridge, UK (GRID:grid.418195.0) (ISNI:0000 0001 0694 2777); University of Cambridge, Department of Physiology, Development and Neuroscience, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); University of Cambridge, Centre for Trophoblast Research, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)




